Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Ebiomedicine|July 28, 2023
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccinationClara Duran-Castells, Anna Prats, Bruna Oriol-Tordera, et al.
Plos One|January 28, 2014
Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaquesViraj Kulkarni, Antonio Valentin, Margherita Rosati, et al.
Scientific Reports|May 29, 2021
Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infectionAnna Prats, Ignacio Martínez-Zalacaín, Beatriz Mothe, et al.
Plos One|November 7, 2015
A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAARTCarmen Elena Gómez, Beatriz Perdiguero, Juan García-Arriaza, et al.
Journal of Virology|August 29, 2014
Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cellsJane C Yaciuk, Matthew Skaley, Wilfried Bardet, et al.
Plos One|January 30, 2014
Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individualsAi Kawana-Tachikawa, Josep M Llibre, Isabel Bravo, et al.
Plos One|September 28, 2017
Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-BMiriam Rosás-Umbert, Beatriz Mothe, Marc Noguera-Julian, et al.
The Journal of Infection|November 9, 2025
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial)Juan Ambrosioni, Elisa de Lazzari, Sonsoles Sánchez-Palomino, et al.
Plos Pathogens|February 28, 2015
Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responsesGemma Hancock, Hongbing Yang, Elisabeth Yorke, et al.
Contemporary Clinical Trials|November 11, 2025
Analytical treatment interruption as a tool in the evaluation of immune-mediated interventions for long-term antiretroviral-free control of HIV-1 among people with HIVAna Gabriela Pires Dos Santos, Manal Abunimeh, Beatriz Mothe, et al.
Pageof 10